This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation

This study has been completed.
The Physicians' Services Incorporated Foundation
Information provided by:
Queen's University Identifier:
First received: August 26, 2005
Last updated: June 13, 2007
Last verified: April 2006
We, the investigators at Queen's University, propose to conduct a randomized, double-blind, feasibility trial comparing low-dose ketamine versus fentanyl as adjuncts to Emergency Department procedural sedation with propofol. The outcomes of interest will be safety, with respect to hemodynamic and respiratory adverse effects, as well as efficacy, with respect to adequacy of sedation and analgesia, recovery profiles and patient/physician satisfaction. Our hypothesis, based on a review of existing anesthesia literature, is that low-dose ketamine may be a safer and more efficacious alternative to fentanyl when used as an adjunct to propofol-assisted procedural sedation.

Condition Intervention
Fractures Dislocations Abscess Anesthesia Analgesia Drug: ketamine

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural Sedation

Resource links provided by NLM:

Further study details as provided by Queen's University:

Primary Outcome Measures:
  • The primary outcome of interest in this study will be the incidence and severity of adverse events during procedural sedation, characterized by using an ordered, four-point categorical scale of airway, ventilatory and hemodynamic adverse events.

Secondary Outcome Measures:
  • The secondary outcome measures of this study will be: the incidence and type of individual adverse events listed in the primary outcome
  • the dose of propofol administered during the procedure
  • times from study drug administration to: beginning of procedure, end of procedure, recovery of appropriate verbal response, Emergency Department discharge, incidence of any adverse event(s)
  • successful completion of the procedure
  • the operator’s rating of the sedation
  • incidence of any adverse drug reaction
  • patient visual analogue scale (VAS) ratings of analgesia, amnesia, and general satisfaction.

Estimated Enrollment: 124
Study Start Date: September 2004
Study Completion Date: August 2006
Detailed Description:

This initial, single-centre feasibility study will have the following specific objectives:

  • Comparison of low-dose ketamine with fentanyl as adjunct to propofol-assisted emergency department procedural sedation, with respect to safety and efficacy parameters;
  • Pilot of a blinded emergency department sedation and analgesia protocol, including drug doses, concealment techniques, and data collection tools, to determine the feasibility of a subsequent larger, multi-centre trial;
  • Determination of the true incidence of the primary outcome measures in the study population, using the study drug administration doses and protocol, such that an accurate sample size may be estimated for a future, adequately-powered, multi-centre trial;
  • Validation of a newly-developed ordered, categorical rating scale for the reporting of respiratory and hemodynamic adverse events occurring during emergency department procedural sedation and analgesia.

Ages Eligible for Study:   14 Years to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Individuals presenting or referred to the Emergency Department at Kingston General Hospital with a fracture or dislocation requiring manipulation under procedural sedation; or abscess requiring incision and drainage under procedural sedation.
  • Ability to provide informed consent according to institutional requirements.
  • Ability to comprehend and communicate in English.

Exclusion Criteria:

  • Age < 14 or > 65 years
  • Any history of significant active cardiac, pulmonary, hepatic or renal disease, as determined by patient history, chart review, or emergency physician.
  • American Society of Anesthesiology (ASA) classification greater than class II.
  • Body mass > 130 kg.
  • A history of physician-diagnosed obstructive sleep apnea.
  • Chronic use of opioids including methadone and buprenorphine.
  • A self-reported history of recent substance abuse or prior opioid dependence.
  • Acute intoxication with drugs or alcohol, based on the judgement of the attending physician.
  • A history of psychotic disorders, as reported by subjects or identified on review of the medical records.
  • A known history of allergy or sensitivity to any study medication.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00137085

Canada, Ontario
Queen's University
Kingston, Ontario, Canada, K7L 3N6
Sponsors and Collaborators
Queen's University
The Physicians' Services Incorporated Foundation
Principal Investigator: Marco LA Sivilotti, MD, MSc Queen's University
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00137085     History of Changes
Other Study ID Numbers: PSI R04-43
Study First Received: August 26, 2005
Last Updated: June 13, 2007

Keywords provided by Queen's University:
procedural sedation

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes
Wounds and Injuries
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Intravenous
Anesthetics, General
Sensory System Agents
Peripheral Nervous System Agents
Anesthetics, Dissociative
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Analgesics, Opioid
Adjuvants, Anesthesia processed this record on September 21, 2017